PON1 Antikörper (AA 9-109)
Kurzübersicht für PON1 Antikörper (AA 9-109) (ABIN6145955)
Target
Alle PON1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 9-109
-
Sequenz
- LLGMGLALFR NHQSSYQTRL NALREVQPVE LPNCNLVKGI ETGSEDLEIL PNGLAFISSG LKYPGIKSFN PNSPGKILLM DLNEEDPTVL ELGITGSKFD V
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Produktmerkmale
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 9-109 of human PON1 (NP_000437.3).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000
-
Kommentare
-
HIGH QUALITY
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- PON1 (Paraoxonase 1 (PON1))
-
Andere Bezeichnung
- PON1
-
Hintergrund
- The enzyme encoded by this gene is an arylesterase that mainly hydrolyzes paroxon to produce p-nitrophenol. Paroxon is an organophosphorus anticholinesterase compound that is produced in vivo by oxidation of the insecticide parathion. Polymorphisms in this gene are a risk factor in coronary artery disease. The gene is found in a cluster of three related paraoxonase genes at 7q21.3.,PON1,ESA,MVCD5,PON,Signal Transduction,Cell Biology & Developmental Biology,Endocrine & Metabolism,Lipid Metabolism,Hydrolysis,Drug metabolism,Endocrine and metabolic diseases,Diabetes,Neuroscience,Neurodegenerative Diseases,Dopamine Signaling in Parkinson's Disease,Cardiovascular,Lipids,Lipoproteins/Apolipoproteins,PON1
-
Molekulargewicht
- 39 kDa
-
Gen-ID
- 5444
-
UniProt
- P27169
Target
-